Skip To The Main Content
pills
NIH STROKENET: PREVENTION TRIALS

Primary and Secondary prevention of stroke is a primary public health concern as approximately 795,000 people in the United States experience a new or recurrent stroke. Efforts in controlling risk factor such as hypertension, diabetes mellitus control, dyslipidemia treatment and smoking cessations programs have had an impact on stroke mortality over the last decade. However stroke remains a leading cause of serious long-term disability in the United States.

CURRENT PREVENTION TRIAL WEBSITES


  • CREST-H:  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis - Hemodynamics
  • CREST-2: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis

 


PRIMARY AND SECONDARY PREVENTION TRIALS

  • Sleep SMART: SLEEP FOR STROKE MANAGEMENT AND RECOVERY TRIAL

  • ARCADIA: ATRIAL CARDIOPATHY AND ANTITHROMBOTIC DRUGS IN PREVENTION AFTER CRYPTOGENIC STROKE

  • CREST-H: CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL - Hemodynamics

  • CREST-2: CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL